Evidence map›Paper›PMID 24970893›Full record

ArticleThe Journal of biological chemistry2014

Dynamic modulation of innate immune response by varying dosages of lipopolysaccharide (LPS) in human monocytic cells.

Matthew C Morris, Elizabeth A Gilliam, Julia Button, Liwu Li

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Clinical manifestations and immune response to tuberculosis.World journal of microbiology & biotechnology · 2023
    Review
  8. Review
  9. GSK3β Inhibition by Phosphorylation at SerInternational journal of molecular sciences · 2022
    Article
  10. Article
  11. The Paradigm Change of IL-33 in Vascular Biology.International journal of molecular sciences · 2021
    Review
  12. Trained immunity contributes to the prevention ofEmerging microbes & infections · 2021
    Review
  13. Article
  14. Transcription Factor EepR Is Required forAntibiotics (Basel, Switzerland) · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Matthew C MorrisFrom the Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061 and.
Elizabeth A Gilliamthe Virginia Tech Carillion School of Medicine, Roanoke, Virginia 24016.
Julia ButtonFrom the Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061 and.
Liwu LiFrom the Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, Virginia 24061 and the Virginia Tech Carillion School of Medicine, Roanoke, Virginia 24016 lwli@vt.edu.
Virginia Tech · US

Funding

Modulation of innate immune cellular homeostasis and inflammation resolutionR01HL115835 · NHLBI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LI, LIWU · 2012 to 2021
$3.6M
NHLBI NIH HHS R01 HL115835
6 · The paper itself

Abstract

Innate monocytes and macrophages can be dynamically programmed into distinct states depending upon the strength of external stimuli. Innate programming may bear significant relevance to the pathogenesis and resolution of human inflammatory diseases. However, systems analyses with regard to the dynamic programming of innate leukocytes are lacking. In this study, we focused on the dynamic responses of human promonocytic THP-1 cells to lipopolysaccharide (LPS). We observed that varying dosages of LPS differentially modulate the expression of selected pro- and anti- inflammatory mediators such as IL-6 and IL-33. Super-low dosages of LPS preferentially induced the pro-inflammatory mediator IL-6, while higher dosages of LPS induced both IL-6 and IL-33. Mechanistically, we demonstrated that super-low and high doses of LPS cause differential activation of GSK3 and Akt, as well as the transcription factors FoxO1 and CREB. Inhibition of GSK3 enabled THP-1 cells to express IL-33 when challenged with super-low dose LPS. On the other hand, activation of CREB with adenosine suppressed IL-6 expression. Taken together, our study reveals a dynamic modulation of monocytic cells in response to varying dosages of endotoxin, and may shed light on our understanding of the dynamic balance that controls pathogenesis and resolution of inflammatory diseases.

Indexed as

Immunity, InnateBase SequenceCell LineDNA PrimersDose-Response Relationship, DrugGene Expression RegulationHumansInflammation MediatorsLipopolysaccharidesMonocytesReal-Time Polymerase Chain ReactionDNA PrimersInflammation MediatorsLipopolysaccharidesinflammationInnate ImmunityLipopolysaccharide (LPS)MonocyteSystems Biology

Identifiers

PMID24970893
PMCPMC4118118
OpenAlexW2093788957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.